Parvovirus B19 (B19V), long known to be the causative agent of erythema infectiosum (fifth disease), is not a newly emerging agent. The aim of this review is to analyse the role played by this virus in compromising safety in transfusion medicine and the progressive measures to reduce the risks associated with the virus.
Human parvovirus B19 and blood product safety. A tale of twenty years of improvements / Marano, Giuseppe; Vaglio, Stefania; Pupella, Simonetta; Facco, Giuseppina; Calizzani, Gabriele; Candura, Fabio; Liumbruno, Giancarlo M.; Grazzini, Giuliano. - In: BLOOD TRANSFUSION. - ISSN 1723-2007. - STAMPA. - 13:2(2015), pp. 184-196. [10.2450/2014.0174.14]
Human parvovirus B19 and blood product safety. A tale of twenty years of improvements
VAGLIO, Stefania;
2015
Abstract
Parvovirus B19 (B19V), long known to be the causative agent of erythema infectiosum (fifth disease), is not a newly emerging agent. The aim of this review is to analyse the role played by this virus in compromising safety in transfusion medicine and the progressive measures to reduce the risks associated with the virus.| File | Dimensione | Formato | |
|---|---|---|---|
|
Marano_Human_2015.pdf
accesso aperto
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
784.1 kB
Formato
Adobe PDF
|
784.1 kB | Adobe PDF | |
|
Marano_Human_2015.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
1.56 MB
Formato
Adobe PDF
|
1.56 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
